Chinook Therapeutics
KDNY
$40.39
Share price
0.00%
Change (1 day)
109.71%
Change (1 year)
Categories
Operating Margin for Chinook Therapeutics (KDNY)
Operating Margin as of May 2024 (TTM): -4,115.55%
According to Chinook Therapeutics's latest financial reports and stock price the company's current Operating Margin is -4,115.55%. At the end of 2022 the company had an Operating Margin of -2,941.81%.
Operating Margin history for Chinook Therapeutics from 2020 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -2,941.81% | 1430.83% |
| 2021 | -192.17% | -98.1% |
| 2020 | -10,111.85% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.